Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Add Yahoo as a preferred source to see more of our stories on Google. This image provided by Pfizer in October shows the company's COVID-19 Paxlovid pills. In December, U.S. health regulators ...

In this photo illustration, Pfizer's Paxlovid is displayed on July 07, 2022 in Pembroke Pines, Florida. (Photo by Joe Raedle/Getty Images) The study found that when excluding hospitalizations and ...

One year ago, Congress defunded public media. Now that we're 100% community funded, please become a sustaining member or increase your existing membership today. There's a lifesaving antiviral drug ...

The antiviral drug nirmatrelvir plus ritonavir (Paxlovid) was granted Emergency Use Authorization for treating COVID-19 in December 2021. In clinical trials, the antiviral was associated with an 88% ...

Researchers have conducted one of the first studies to examine the effectiveness of nirmatrelvir-ritonavir (Paxlovid) in non-hospitalized patients during an omicron period of the COVID-19 pandemic ...

Dear Doctors: Our dad is 77 years old and has diabetes. He got sick with COVID-19 this summer, and it was a huge struggle to get him to take the Paxlovid his doctor prescribed. The process made me ...

A recent preprint study found that Pfizer’s COVID-19 antiviral Paxlovid may be effective in reducing the risk of developing long COVID in patients recovering from coronavirus infections. The study, ...

Add Yahoo as a preferred source to see more of our stories on Google. Taking the antiviral treatment Paxlovid can reduce a person's chances of getting seriously ill from COVID-19. But while seniors ...

One year ago, Congress defunded public media. Now that we're 100% community funded, please become a sustaining member or increase your existing membership today. There is a new push from the White ...

With the recent uptick in COVID-19 cases prompted by the JN.1 variant, I've wondered how effective Paxlovid is in treating these cases, especially in older people. When should it be prescribed? And ...